Company
Occlutech
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1
510(k), De Novo and PMA
Device trials
14
As lead sponsor, any status
Adverse event reports
58
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Occlutech, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
No 5%+ shareholder filings, SBIR grants or venture investors found under the name Occlutech.
Latest FDA decisions
P200032 · Decided Dec 29, 2023 · 1,270 days after receipt
Device type: Transcatheter septal occluder (atrial) (OZG) · Cardiology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO OcclusionPivotal-lookingActive, not recruiting
NCT05069558 · 450 participants (planned) · Start May 9, 2022 · Primary completion Nov 30, 2025
Device: Investigational PFO Closure Device; Standard of Care PFO Closure Device · For: Stroke; Patent Foramen Ovale; PFO
Sites: Phoenix, Arizona; Stanford, California; Thousand Oaks, California · 48 sites in all
13 more trials with a free account
Reports received
58
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
34
59% of reports
Injury reports
24
41% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 1 | 0 |
| Mar 24 | 0 | 2 | 0 | 0 |
| Apr 24 | 0 | 1 | 0 | 0 |
| May 24 | 0 | 1 | 0 | 0 |
| Jun 24 | 0 | 2 | 0 | 0 |
| Jul 24 | 1 | 1 | 0 | 0 |
| Aug 24 | 0 | 1 | 0 | 0 |
| Sep 24 | 0 | 2 | 0 | 0 |
| Oct 24 | 0 | 3 | 0 | 0 |
| Nov 24 | 0 | 3 | 0 | 0 |
| Dec 24 | 0 | 3 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 1 | 0 | 0 |
| Apr 25 | 0 | 5 | 0 | 0 |
| May 25 | 0 | 1 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 4 | 0 | 0 | 0 |
| Aug 25 | 2 | 3 | 0 | 0 |
| Sep 25 | 3 | 4 | 0 | 0 |
| Oct 25 | 5 | 5 | 0 | 0 |
| Nov 25 | 1 | 4 | 0 | 0 |
| Dec 25 | 0 | 1 | 0 | 0 |
| Jan 26 | 3 | 3 | 0 | 0 |
| Feb 26 | 3 | 0 | 0 | 0 |
| Mar 26 | 3 | 5 | 0 | 0 |
| Apr 26 | 4 | 1 | 0 | 0 |
| May 26 | 0 | 3 | 0 | 0 |
| Jun 26 | 4 | 0 | 0 | 0 |
| Jul 26 | 1 | 2 | 0 | 0 |
| Aug 26 | 3 | 0 | 0 | 0 |
| Sep 26 | 10 | 3 | 0 | 0 |
| Oct 26 | 2 | 2 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
1 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.